# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-030298
Filing Date
2024-08-05
Accepted
2024-08-05 17:27:04
Documents
11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form424b3.htm | 424B3 | 2997258
2 |  | forms-1_001.jpg | GRAPHIC | 10244
3 |  | form10-k_002.jpg | GRAPHIC | 119366
4 |  | form10-k_003.jpg | GRAPHIC | 75749
5 |  | form10-k_004.jpg | GRAPHIC | 59453
6 |  | form10-k_005.jpg | GRAPHIC | 114184
7 |  | form10-k_006.jpg | GRAPHIC | 121592
8 |  | form10-k_007.jpg | GRAPHIC | 71159
9 |  | form10-k_008.jpg | GRAPHIC | 26799
10 |  | form10-k_009.jpg | GRAPHIC | 119739
11 |  | form10-k_010.jpg | GRAPHIC | 55116
| Complete submission text file | 0001493152-24-030298.txt |  | 4064823

Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280414 | Film No.: 241176167
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)